Projek Penyelidikan

Projek Tempoh Peranan
exploring diet, physical activities and host’s interaction with colonic mucosal microbiota population in young colorectal cancer 24-09-202023-09-2024 Penyelidik Bersama
unravelling the ecobiosocial factors in colorectal cancer initiation and progression 07-09-202106-09-2024 Penyelidik Bersama
combining microbial, integrin expression and dietary pattern in crohn’s disease patients treated with anti-integrin 01-09-202131-08-2024 Penyelidik Bersama
combined phase 3, double-blind, randomized, placebo-controlled studies evaluating the efficacy and safety of filgotinib in the induction and maintenance of remission in subjects with moderately to severely active crohn`s disease 16-03-201715-07-2024 Penyelidik Bersama
m14-675: a multicenter, randomized, double-blind, placebo-controlled induction study to evaluate the efficacy and safety of upadacitinib (abt-494) in subjects with moderately to severely active ulcerative colitis 13-06-201912-06-2024 Penyelidik Bersama
the clinical utility of biomarkers afp-l3 and pivka ii as a tool for hepatocellular carcinoma screening in ukmmc 24-02-202223-05-2024 Penyelidik Bersama
tocotrienol as a treatment for non-alcoholic fatty liver disease: a randomized controlled trial 10-04-202009-04-2024 Penyelidik Bersama
tocotrienol as a treatment for non-alcoholic fatty liver disease: a randomized controlled trial 10-04-202009-04-2024 Penyelidik Bersama
- 10-01-202209-01-2024 Ketua Projek
tajuk program: linking obesity to cancer: an integrative study from molecule to society tajuk projek: identification of risk factors associated with colon cancer prognosis, disease free survival and recurrence in obese individuals 01-02-201931-12-2023 Penyelidik Bersama
a phase 3, multicenter, randomized, double-blind, parallel, placebo-controlled induction study of mirikizumab in conventional-failed and biologic-failed patients with moderately to severely active ulcerative colitis(protocol no: 16t-mc-aman) 27-12-201826-10-2023 Penyelidik Bersama
a multicenter, randomized, double-blind, placebo-controlled induction study of the efficacy and safety of risankizumab in subjects with moderately to severely active crohn`s disease 14-09-201713-07-2023 Penyelidik Bersama
gs-us-384-1943: a phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of selonsertib in subjects with nonalcoholic steatohepatitis (nash) and bridging (f3) fibrosis 13-07-201712-07-2023 Penyelidik Bersama
determining the efficiency of antifoaming agents in improving the visibility of gastric mucosa in patient undergoing oesophagogastroduodenoscopy (ogds) in universiti kebangsaan malaysia medical centre (ukmmc) 07-06-202206-06-2023 Penyelidik Bersama
development and clinical evaluation on aptamer-based synthetic antibody for leucine-rich 2-glycoprotein 1 (lrg1) detection in human serum of colorectal cancer 01-09-202031-05-2023 Penyelidik Bersama
a multicenter, randomized, double-blind, placebo controlled maintenance and long term extension study of the efficacy and safety of upadacitinib (abt-494) in subjects with crohn’s disease who completed the m14-431 or m14-433 studies 12-04-201811-04-2023 Penyelidik Bersama
a phase 3, multicenter, randomized, double-blind, parallel-arm, placebo-controlled maintenance study of mirikizumab in patients with moderately to severely active ulcerative colitis.protocol no: 16t-mc-ambg 27-12-201826-02-2023 Penyelidik Bersama
a phase 3 multicenter, open-label extension (ole) study to evaluate the long-term safety and efficacy of abt-494 in subjects with ulcerative colitis (uc) 16-02-201715-02-2023 Penyelidik Bersama
a long-term extension study to evaluate the safety of filgotinib in subjects with ulcerative colitis 13-04-201712-12-2022 Penyelidik Bersama
a multicenter, randomized, double-blind, placebo-controlled 52-week maintenance and an open-label extension study of the efficacy and safety of risankizumab in subjects with crohn`s disease who responded to induction treatment in m16-006 or m15-991 26-10-201725-11-2022 Penyelidik Bersama
a multicenter, randomized, double-blind, placebo-controlled induction study to assess the efficacy and safety of risankizumab in subjects with moderately to severely active crohn`s disease who failed prior biologic treatment 14-09-201713-10-2022 Penyelidik Bersama
unravelling driver mutations of phosphatidylinositol 3-kinase pathway genes leading to the development of colitis associated cancer 01-01-201930-09-2022 Penyelidik Bersama
effectiveness of interactive video on colorectal cancer screening: a quasi experiment in primary healthcare settings 26-03-202025-09-2022 Penyelidik Bersama
assessment of dysphagia in post laryngectomy patient in hospital canselor tuanku muhriz, (hctm,ppukm) : a cross sectional study 30-01-202029-06-2022 Penyelidik Bersama
a multicenter, randomized, double-blind, placebo-controlled induction study of the efficacy and safety of upadacitinib (abt-494) in subjects with moderately to severely active crohn’s disease who have inadequately responded to or are intolerant to 12-04-201811-04-2022 Penyelidik Bersama
a multicenter, randomized, double-blind, placebo-controlled induction study of the efficacy and safety of upadacitinib (abt-494) in subjects with moderately to severely active crohn`s disease who have inadequately responded to or are intolerant to biologi 12-04-201811-04-2022 Penyelidik Bersama
revealing fecal short chain fatty acids as gut microbiota-derived biomarker in non-alcoholic fatty liver disease 01-10-201931-03-2022 Penyelidik Bersama
elucidating probiotics as gut microenvironment modulator in non-alcoholic fatty liver disease 01-01-201931-03-2022 Penyelidik Bersama
health-related quality of life of inflammatory bowel disease patients in malaysia 26-03-202025-03-2022 Penyelidik Bersama
the effectiveness of intestinal ultrasound in the assessment of inflammatory bowel disease: a prospective study at a tertiary ibd centre 13-09-201911-03-2022 Penyelidik Bersama
clinical characteristics of colorectal cancer patients in ukmmc from 1997 to 2017 22-02-201821-02-2022 Penyelidik Bersama
prevalence of liver injury in covid-19 18-02-202117-02-2022 Ketua Projek
a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of abt-494 for induction and maintenance therapy in subjects with moderately to severely active ulcerative colitis 16-02-201715-02-2022 Penyelidik Bersama
combined phase 2b/3, double-blind, randomized, placebo-controlled studies evaluating the efficacy and safety of filgotinib in the induction and maintenance of remission in subjects with moderately to severely active ulcerative colitis 13-04-201712-02-2022 Penyelidik Bersama
phase iii, randomized, double-blind, double-dummy, placebo-controlled, multicenter study to evaluate the efficacy (induction of remission) and safety of etrolizumab compared with adalimuman and placebo in patients with moderate to severe ulcerative coliti 26-02-201525-12-2021 Penyelidik Bersama
the effect of probiotic as an adjunct treatment for helicobacter pylori infection in adult 24-12-202023-12-2021 Penyelidik Bersama
effect of low-fodmap diet on clinical and histopathological outcomes of patients with functional dyspepsia 12-11-202011-11-2021 Penyelidik Bersama
real-world practice on the efficacy and safety of antiviral therapy in the management of symptomatic covid-19 infection 11-06-202010-06-2021 Penyelidik Bersama
addressing gut health, diet and physical activities: focus on post-gestational diabetes women 01-09-201730-11-2020 Penyelidik Bersama
targeting transcripts related to inflammation in long duration inflammatory bowel disease 02-05-201801-05-2020 Penyelidik Bersama
the role and effect of dietary intake variation (low fodmaps diet intervention) on gut microbiota in a multi-ethnic population with irritable bowel syndrome 30-03-201929-03-2020 Ketua Projek
the effect of probiotic as adjunct treatment for gastroesophageal reflux disease (gerd) in adults 24-12-201823-12-2019 Penyelidik Bersama
targeting transcripts related to inflammation in long duration inflammatory bowel disease 16-10-201715-10-2019 Penyelidik Bersama
extraintestinal manifestation of inflammatory bowel disease in asia: a multinational retrospective study 30-08-201829-08-2019 Ketua Projek
an evaluation of cultured milk drink on immune status of patients with irritable bowel syndrome : constipation-predominant 11-05-201710-05-2019 Penyelidik Bersama
adherence to suveillance guideline after removal of colorectal polyps: a multi-national,multi center,prospective study 30-08-201829-03-2019 Ketua Projek
colonoscopic polypectomy practices among asian gastrointestinal endoscopists: a multi-national, multi-center, prospective survey 16-08-201815-03-2019 Ketua Projek
the impact and effectiveness of clinical pathway in outpatient management of irritable bowel syndrome universiti kebangsaan malaysia medical centre (ukmmc) 14-12-201713-12-2018 Penyelidik Bersama
assessment of correlation between non alcoholic fatty liver disease and severity of coronary artery disease in young acute coronary syndrome in ukmmc 30-11-201729-11-2018 Penyelidik Bersama
prevalence of irritable bowel syndrome in urban setting 30-03-201729-09-2018 Penyelidik Bersama
paradigm of clinical characterics among ibd patients and ibd associated neoplasia in a malaysian multi ethic cohort 11-05-201710-04-2018 Penyelidik Bersama
liver abscess - a 15 years retrospective analysis of the trend and clinical outcome in national university of malaysia hospital (ppukm) 14-09-201713-01-2018 Penyelidik Bersama
normal values for high-resolution oesophageal manometry and 24-hours ambulatory ph-impedance monitoring in a malaysian cohort of healthy subjects 21-08-201520-07-2017 Penyelidik Bersama
a phase 3 clinical trial to study the short duration versus standard response-guided therapy with mk-3034 (sch 503034)/boceprevir combined with peglntron and ribavirin in previously untreated non-cirrhotic subjects with chronic hcv genotype 1 in asia 02-01-201401-01-2017 Penyelidik Bersama
development of rapid molecular-based method for diagnosis of helicobacter pylori infection and antibiotic resistance 01-12-201330-11-2016 Penyelidik Bersama
an international multicenter prospective observational study to evaluate the epidemiology, humanistic and economic outcomes of treatment for chronic hepatitis c virus (hcv) 30-10-201429-11-2016 Penyelidik Bersama
a phase 3, safety and efficacy study of boceprevir/peginterferon alfa-2a/ribavirin in chronic hcv genotype 1 il28b cc subjects 01-05-201231-05-2016 Penyelidik Bersama
assessment of awareness of hepatocellular carcinoma(hcc)among patients with chronic hepatitis b and c attending gastroenterology clinic in ukm medical centre 21-01-201420-01-2015 Ketua Projek